|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02427 GUANZE MEDICAL
Nominal 
0.430 +0.010 (+2.381%) | 2023/12 - Final RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 8,848 | 9,315 | 3,093 | 28,168 | 5,511 |
| Net Cash from / (used in) Investing Activities | (7,304) | (9,329) | (7,856) | (14,349) | (9,831) |
| Net Cash from / (used in) Financing Activities | 37,438 | 9,147 | 19,477 | (14,792) | (3,868) |
| Increase / (Decrease) in Cash & Cash Equivalents | 38,982 | 9,133 | 14,714 | (973) | (8,188) |
| Cash & Cash Equivalents at beginning of period | 29,368 | 20,235 | 5,521 | 6,494 | 14,682 |
| Effect of Foreign Exchange Rate Changes | 0 | 0 | 0 | 0 | 0 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 68,350 | 29,368 | 20,235 | 5,521 | 6,494 |
| Remarks: | Real time quote last updated: 15/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -160,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.000 |
| NBV Per Share (¥) | RMB 0.254 |